INTRODUCTION
Cancer of the mammary gland is still one of the leading causes of death from tumor among women in western countries. However, breast cancer is not a single disease but includes several different forms grouped as invasive and noninvasive types. Among the invasive histotypes, ductal infiltrating carcinoma (DIC) is the most common and aggressive form of breast cancer. 1 It usually has a poor prognosis and represents the standard histotype with which the other less frequent subtypes (i.e., papillary, mucinous-colloid, tubular, medullary carcinomas) are compared. Carcinomas are potentially malignant tumors of epithelial origin, which, once genetically "initiated," grow, progress, invade, and spread in the body with a common phenomenology regardless of their individual derivation.
The major cellular changes involved in the conversion of a normal to a malignant breast are the progressive loss of the stationary epithelial phenotype (consisting of polarized morphology and specific cell-cell and cell-matrix adhesion systems) and the acquisition of a mesenchymal-like phenotype, correlated with the ability to migrate and invade surrounding and distant tissues, even under conditions of a low oxygen supply. These aspects are related to multiple gene defects, whose functional network is hard to understand from a global point of view.
According to recent estimation, the human genome encodes at least 30,000-40,000 structural genes. 2, 3 However, due to posttranscriptional and posttranslational modifications, the number of proteins expressed by cells may be several times higher. In addition, posttranslational modifications may be instrumental in altering or adding functions to certain proteins and their oligomeric forms. Therefore, detecting protein profiles, directed towards knowledge of both the identity and the relative quantity of proteins (and their isoforms) in tumors, is the challenge of the postgenomic era. Comparative profiling of paired tumoral and normal counterparts may provide substantial information on qualitative and quantitative modifications of cancer-associated gene expression, which in turn can be fundamental in understanding molecular mechanisms involved in cancer development. The proteomic strategy, based on a high-resolution two-dimensional immobilized pH gradient (2D-IPG) and related techniques (computer-assisted image analysis, microsequencing, and immune detection), is a powerful tool for the separation, detection, and analysis of a large number of proteins on the same preparation, without prior knowledge of their identity.
The study of protein expression in primary human breast cancer (as for most solid tumors), however, is difficult because breast tumors may contain several different cell types, other than carcinoma cells, such as additional epithelial cell types, stromal cells, and infiltrating lymphocytes. On the other hand, laser-capture microdissected sections 4 may contain large amounts of proteins resident in the extracellular interstitium as albumin, globulins, and other serum proteins. Therefore, several laboratories, including ours, have developed an appropriate in vitro model of normal and neoplastic mammary cells for biological and molecular assays [5] [6] [7] [8] including the recent approach on cDNA microarray 9 and proteomics. 10 Among the breast cancer cell lines described to date in the literature, 8701-BC 5 deserves particular interest, because it was established from a primary DIC, that is, before clonal selection of the metastatic process. As a nontumoral reference cell line, we used HB2 cells 7 that maintain in culture the lumenal mammary phenotype, which represents the most common target of mammary cancer.
On protein separation by 2D-IPG and computer processing of the 2D gels, we searched for qualitative (presence/absence) and quantitative (relative abundance) differences in protein profiles to identify relevant differences and homologies between the two representative cell lines.
Within an analysis window comprising about 1,750 discernible spots, we have currently catalogued 140 proteins of potential interest, 58 of which were identified by gel matching, immunodetection, or N-terminal microsequencing. Twelve proteins were differentially expressed in the two cell lines: four were expressed uniquely by neoplastic cells and eight by epithelial cells. In addition, 53 proteins of 140 selected in the map displayed different relative quantities, namely, 44 proteins were more elevated in cancer cells and 9 in HB2 cells.
Interestingly, among proteins with higher relative expression levels in cancer cells (at least 1.5-to 3-fold) we identified several glycolytic enzymes and their isoforms. This finding is of interest, because the "Warburg effect" (enhanced anaerobic metabolism in cancer) has long been known, but this is the first report of increased levels of these enzymes in cancer cells at the proteomic level. Therefore, due to their easy detection on the 2D map, the present approach could have great clinical application.
MATERIAL AND METHODS

Cell Culture
Cells were grown in the appropriate culture medium supplemented with 10% fetal calf serum (FCS; GIBCO) and antibiotics (100 units/ml penicillin and 100 µg/ ml streptomycin) in a humidified incubator with 3% CO 2 in air at 37°C. The culture medium was RPMI 1640 for the 8701-BC 5 and Dulbecco's modified Eagle's medium (DMEM) supplemented with hydrocortisone (5 µg/ml) and insulin (10 µg/ml) for the HB2 human mammary epithelial cell line. 7 
Sample Preparations
Cells were grown to confluence and then incubated with three changes of serumfree medium. After washing with ice-cold phosphate-buffered saline solution, they were carefully scraped and incubated in ice for 30 minutes with RIPA buffer (50 mM Tris pH 7.5, 0.1% nonidet P-40, 0.1% deoxycholate, 150 mM NaCl, 4 mM EDTA, and a mixture of protease inhibitors, 0.01% aprotinin, 10 mM sodium pyrophosphate, 2 mM sodium orthovanadate, and 1 mM PMSF). The total cellular lysate was centrifuged at 14,000 rpm for 8 minutes to clear cell debris, and the supernatant was dialyzed against ultrapure distilled water, lyophilized, and stored at −80°C until analysis. Protein concentration in the cellular extracts was determined using the Breadford method.
Two-Dimensional Gel Electrophoresis
Aliquots of dried cell lysate were solubilized in buffer containing 8 M urea, 4% CHAPS, 40 mM Tris, 65 mM DTE (1,4-dithioerythritol), and trace amounts of bromophenol blue.
The first dimensional separation was performed at 20°C on commercial sigmoidal immobilized pH gradient strips (IPG) 18 cm long, pH 3.5-10 (Pharmacia), essentially as described by Görg et al. 11 and Bjellqvist et al. 12 Strips were rehydrated in 8 M urea, 2% CHAPS, 10 mM DTE, and 0.5% carrier ampholytes (resolyte 3.5-10). Aliquots of 45 µg (analytical gels) or 1.5 mg (preparative gels) total proteins were applied to the gel strip. Isoelectrofocusing was carried out by linearly increasing voltage from 200-3,500 V during the first 4.5 hours, after which focusing was continued at 8,000 V for 8 hours. After the run, the IPG strips were equilibrated with a solution containing 6 M urea, 30% glycerol, 2% SDS, 0.05 M Tris-HCl pH 6.8, and 2% DTE for 12 minutes to resolubilze proteins and reduce disulfur bonds. The -SH groups were then blocked by substituting the DTE with 2.5% iodoacetamide in the equilibrating buffer.
The focused proteins were then separated on 9-16% linear gradient polyacrylamide gels (SDS-PAGE) with a constant current of 40 mA/gel at 10°C. Gels were stained with ammoniacal silver nitrate, as described by Hochstrasser et al. 13 
Image Acquisition and Data Analysis
Silver-stained gels were digitized using a computing densitometer and processed with a Melanie 3 computer system (GeneBio). Gel calibration was carried out on the basis of internal standard with the support of the ExPaSy molecular biology server. Quantitative variations of proteins were expressed as volumes of spots (i.e., integration of optical density over the spot area). To correct for differences in gel staining, relative volumes to the sum of the volume of all spots in each gel were calculated with the Melanie system and plotted with the Excel program. For figure presentation, images were transferred to Adobe Photoshop and PowerPoint programs.
Protein Microsequencing
N-terminal microsequencing was performed by automated Edman degradation in an Applied Biosystem protein sequenator (Procise, Perkin-Elmer) on protein samples electrotransferred onto polyvinylidene difluoride membranes (Immobilon-PTM, Millipore). The SWISS-PROT (ScanProsite) and EMBL (Bic 2) databases were used for online sequence similarity search at http://expasy.hcuge.ch/.
RESULTS
The In Vitro Model
As an in vitro model for present research, we used two representative cell lines: the 8701-BC, derived from a primary ductal infiltrating carcinoma, 5 which shows invasive behavior both in vivo and in vitro, [14] [15] [16] and the nontumorigenic HB2 cell line, derived from immortalized human lumenal mammary epithelial cells, 7 kindly supplied by Dr. J. Taylor-Papadimitriou (Imperial Cancer Research Fund, London, United Kingdom) and presently cultivated in our laboratory. FIGURE 1 shows representative phase-contrast micrographs of the two cell cultures at the following time of growth: 24 hours, 48 hours, 72 hours, and 1 week after seeding. As can be observed in the micrographs from A to D, the neoplastic cells display an apolarized morphology with irregular profiles; they spread over the substrate with emission of spikes and once they reach confluence, they overgrow, forming typical domes (FIG. 1D) . On the contrary, HB2 cells (FIG. 1E-H) maintain in vitro the morphology of epithelial cells, being polarized and responsive to contact inhibition.
Proteomic Profiles of the 8701-BC and HB2 Cell Lines
Each cell culture was grown until confluence, deprived of serum, and then processed for lysis and two-dimensional-IPG separation, as described in Material and Methods. FIGURES 2 and 3 show the miniature of two representative 2D maps of the 8701-BC and HB2 cells, respectively. The crosses on the spots as well as the grid indicating pI and Mr were assigned by the Melanie system after cleaning out the background from maps. The number of spots was 1,747 in cancer cells and 1,753 in HB2 cells.
Protein Identification and Clustering in the 8701-BC Map
Protein identification in the 8701-BC map was performed by gel matching, immunodetection, or N-terminal microsequencing, as described in Material and Methods. Currently, 58 proteins (including isoforms) were identified in the map and grouped according to their major functions. The first group includes cytoskeletal proteins, the second group folding, chaperons, and heat-shock proteins, the third 
Proteome Comparison between 8701-BC and HB2 Cells
A representative number of 140 spots was arbitrarily selected to achieve unambiguous gel matching between the two maps. This number represents a significant subset of proteins in the proteomic map, corresponding to about 8% of the total amount, and includes the proteins already identified and proteins with unknown identity (U), because they were absent from the data banks or N-terminal blocked. Their identification will be the object of further studies .
Triplicate experiments were performed to ensure reproducible protein separation; to exclude ambiguous spots, synthetic gels of the two cell preparations were constructed by means of the Melanie algorithms. FIGURE 4 shows the synthetic gel of the 8701-BC cell preparation and FIGURE 5 that obtained from HB2 cells. The iden- tified proteins are indicated with abbreviations used by the Swiss-Prot database; the spots corresponding to proteins with unknown identity are indicated with numbers. Qualitative differences (presence/absence of spots) were observed within both groups of proteins with known and unknown identity. Proteins present in cancer cells and absent in the HB2 cell map were: the ubiquitin carboxyl-terminal hydrolase isozyme (UBL 1), an isoelectric variant of glutathione S-transferase (GSTP), and two proteins with unknown identity (spot numbers 35 and 36). Conversely, eight spots out of the panel of those selected (namely, 2a, 2b, 2c, 51a, 54, 65a, 65b, and 65c) were uniquely present in the HB2 cell map. (Note that arrows point to corresponding positions of the expected spot, even in the absence of discernible stain.)
After qualitative analysis, we performed comparative quantitation of the comprehensive spectrum of selected protein spots, except the cytokeratins, which were identified by separate western blot analysis (not shown). The comparison was made by As can be observed in the histograms, the profiles of the sampled protein are notably distinct in the two cell lines, because about 37% of the selected protein spots displayed variable levels of relative abundance in the two proteomes; in particular, 44 were overexpressed in cancer cells and 9 in epithelial cells, whereas the remainder displayed similar levels of expression in both maps. Proteins that showed higher intensity in cancer cells included glycolytic enzymes, chaperonins, and others with specific roles in biosynthesis and cellular metabolism. Conversely, no significant differences were found among the group of cytoskeletal proteins.
Among the glycolytic enzymes, glyceraldehyde-3-phosphate dehydrogenase (G3P2) showed an average increase of 1.5-fold relative to the control map. However, the various isoforms increased to a different extent, with the highest level of 2.5-fold exhibited by isoform c (TABLE 3) . Similarly, alpha-enolase displayed an average increase of 1.7-fold, with the greatest difference for isoform c. An increment was also observed for fructose bisphosphate aldolase (1.37-fold for ALFA a and 1.5-fold for isoform b) and for pyruvate kinase (1.74-fold for KPY1 and 1.9-fold for KPY2). By contrast, no essential differences were observed for triosephosphate isomerase (TPIS).
Among the group of chaperonins, one isoform of mitochondrial molecular chaperone heat-shock protein 60 (HSP60) was found almost differentially present in cancer cells, whereas disulfide isomerase ER-60 (ERP 60) and peptidil prolyl cis-trans isomerase (CYPH) showed increased levels of about twofold. A similar difference was found for elongation factor Tu (EFTU), thioredoxin (THIO), superoxide dismutase (SOD), oncosuppressor p53, and the MA32 glycoprotein, all proteins that play an active role in controlling cell proliferation and biosynthesis. Conversely, tumor rejection antigen 1 (TRA) and collagen binding protein (CBP2) were more expressed in HB2 cells.
Concerning proteins of unknown identity (marked U followed by the number assigned in the 2D maps in FIGS. 2 and 3), two were uniquely present in cancer cells, as already mentioned (U35 and U36), and 22 were highly overexpressed (FIG. 7) . The proteins overexpressed, or uniquely present, in epithelial cells relative to cancer cells are shown in FIGURE 8.
DISCUSSION
The proteomic strategy, based on two-dimensional gel electrophoresis and related techniques for protein identification and quantification, is a growing field of research in a world-wide dimension. However, comprehensive protein profiling in cancer occurs at its beginning. This work has contributed to the knowledge of breast cancer See previous page for legend.
proteomics, using an in vitro model consisting of the well-characterized breast cancer cell line 8701-BC 5 and a human mammary epithelial cell line, HB2. 7 Within the limitation of cultured cells, the two cell lines represent a suitable model, because each of them maintains in culture the specific features of their original in vivo status: HB2 cells display a polarized phenotype and are responsive to contact inhibition, whereas 8701-BC cells have pleomorphic morphology and overgrow, forming typical domes. Both of them express cytokeratin 8 and 18, which is typical of lumenal mammary cells. However, 8701-BC cells display isoelectric variants of the two cytokeratin forms, which are absent in normal cells (work in progress).
Within the experimental window of the 2D-IPG used, an average of 1,750 spots was detected by the Melanie system. To establish a significant area of overlapping between maps, we arbitrarily chose a subset of 140 representative spots, covering the 8% of the total protein complement in the maps. Fifty-eight proteins (including isoforms) were identified by gel matching with reference maps, immunodetection, or N-terminal microsequencing and were classified according to their major functions. Of these, 9 belong to the class of cytoskeletal proteins, 18 to chaperonins and affine proteins, 23 are proteins involved in metabolism and biosynthesis, and 8 are involved in regulatory functions.
Results of computer-assisted matching of the neoplastic cell protein profile versus the normal epithelial cell profile demonstrated that within our selected protein sample, 12 proteins, four of which were uniquely present in the cancer cells, were differentially expressed in the two cell lines. Among these were isoelectric variants of glutathione S-transferase (GSTP) and the ubiquitin carboxyl-terminal hydrolase isozyme (UBL 1). The latter is a thiol protease involved in the processing of both ubiquitin precursors and ubiquinated proteins. It is interesting that this enzyme was originally found in neurons and cells of the diffuse neuroendocrine system and their tumors; therefore, its presence and function in breast cancer cells deserve further study.
In measuring changes in relative intensity within the subset of 140 protein spots, we found differences in about 37% of them, that is, 44 proteins were more elevated in cancer cells and 9 in epithelial cells.
Interestingly, most proteins overexpressed in cancer cells belong to the group of glycolytic enzymes. Elevated levels of anaerobic metabolism, even in the presence of oxygen, known as the "Warburg effect" after the scientist's discovery seven decades ago, are a frequent clinical syndrome in oncologic patients. 13 However, the relative increment in glycolytic enzymes (or their isoforms) at the protein expression level was unexpected, because they are thought to be constitutively expressed by cells; in particular, G3P2 is used as one of the housekeeping genes to normalize transcriptional levels of other messengers in several experimental models.
Comparing our breast cancer cell map with that available on line (http://www.expasy.ch/ch2d/), we found that DIC tissues 17 consistently and reproducibly show in- creased levels of glycolytic enzymes in comparison with paired healthy tissues of the same patients. This observation allows us to conclude that the increased level of glycolytic enzymes in vivo is also maintained in cultured cancer cells and therefore may represent part of early oncogenic transformation in cancer rather than a mere adaptive response of tumor cells to the low oxygen supply in the host microenvironment.
This hypothesis is supported by recent molecular studies revealing that several of the multiple genetic alterations involved in tumor development directly affect glycolysis, which in turn increases the ability of tumor cells to recruit new blood vessel metabolism (Ref. 18 and references therein).
In conclusion, our current data have contributed to the knowledge of proteomic profiling of breast cancer cells. While indicating homologies with data already reported in vivo, they add new information on cancer-related proteomics, the knowledge of which will greatly enhance our understanding of molecular pathways involved in cancer development.
